Literature DB >> 19256469

Catalytic properties of botulinum neurotoxin subtypes A3 and A4.

James S Henkel1, Mark Jacobson, William Tepp, Christina Pier, Eric A Johnson, Joseph T Barbieri.   

Abstract

Botulinum toxins (BoNT) are zinc proteases (serotypes A-G) which cause flaccid paralysis through the cleavage of SNARE proteins within motor neurons. BoNT/A was originally organized into two subtypes, BoNT/A1 and BoNT/A2, which are approximately 95% homologous and possess similar catalytic activities. Subsequently, two additional subtypes were identified, BoNT/A3 (Loch Maree) and BoNT/A4 (657Ba), which are 81 and 88% homologous with BoNT/A1, respectively. Alignment studies predicted that BoNT/A3 and BoNT/A4 were sufficiently different from BoNT/A1 to affect SNAP25 binding and cleavage. Recombinant light chain (LC) of BoNT/A3 (LC/A3) and BoNT/A4 (LC/A4) were subjected to biochemical analysis. LC/A3 cleaved SNAP25 at 50% of the rate of LC/A1 but cleaved SNAPtide at a faster rate than LC/A1, while LC/A4 cleaved SNAP25 and SNAPtide at slower rates than LC/A1. LC/A3 and LC/A4 had similar K(m) values for SNAP25 relative to LC/A1, while the k(cat) for LC/A4 was 10-fold slower than that for LC/A1, suggesting a defect in substrate cleavage. Neither LC/A3 nor LC/A4 possessed autocatalytic activity, a property of LC/A1 and LC/A2. Thus, the four subtypes of BoNT/A bind SNAP25 with similar affinity but have different catalytic capacities for SNAP25 cleavage, SNAPtide cleavage, and autocatalysis. The catalytic properties identified among the subtypes of LC/A may influence strategies for the development of small molecule or peptide inhibitors as therapies against botulism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19256469      PMCID: PMC2701208          DOI: 10.1021/bi801686b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Enzymatic autocatalysis of botulinum A neurotoxin light chain.

Authors:  S A Ahmed; M P Byrne; M Jensen; H B Hines; E Brueggemann; L A Smith
Journal:  J Protein Chem       Date:  2001-04

2.  Crystal structure of botulinum neurotoxin type A and implications for toxicity.

Authors:  D B Lacy; W Tepp; A C Cohen; B R DasGupta; R C Stevens
Journal:  Nat Struct Biol       Date:  1998-10

3.  Case of infant botulism in Texas.

Authors:  B J Edmond; F A Guerra; J Blake; S Hempler
Journal:  Tex Med       Date:  1977-10

4.  Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.

Authors:  P Foran; G W Lawrence; C C Shone; K A Foster; J O Dolly
Journal:  Biochemistry       Date:  1996-02-27       Impact factor: 3.162

5.  Role of the heavy and light chains of botulinum neurotoxin in neuromuscular paralysis.

Authors:  S Bandyopadhyay; A W Clark; B R DasGupta; V Sathyamoorthy
Journal:  J Biol Chem       Date:  1987-02-25       Impact factor: 5.157

6.  Sequence homology and structural analysis of the clostridial neurotoxins.

Authors:  D B Lacy; R C Stevens
Journal:  J Mol Biol       Date:  1999-09-03       Impact factor: 5.469

7.  Proteolysis of SNAP-25 by types E and A botulinal neurotoxins.

Authors:  T Binz; J Blasi; S Yamasaki; A Baumeister; E Link; T C Südhof; R Jahn; H Niemann
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

8.  Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.

Authors:  S Ashraf Ahmed; Mark A Olson; Matthew L Ludivico; Janice Gilsdorf; Leonard A Smith
Journal:  Protein J       Date:  2008-04       Impact factor: 2.371

9.  Botulinum neurotoxins are zinc proteins.

Authors:  G Schiavo; O Rossetto; A Santucci; B R DasGupta; C Montecucco
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

10.  Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins.

Authors:  G Schiavo; C C Shone; M K Bennett; R H Scheller; C Montecucco
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

View more
  26 in total

1.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

Review 2.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

3.  Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.

Authors:  Karine Bagramyan; Bruce E Kaplan; Luisa W Cheng; Jasmin Strotmeier; Andreas Rummel; Markus Kalkum
Journal:  Anal Chem       Date:  2013-05-22       Impact factor: 6.986

4.  Entry of Botulinum Neurotoxin Subtypes A1 and A2 into Neurons.

Authors:  Abby R Kroken; Faith C Blum; Madison Zuverink; Joseph T Barbieri
Journal:  Infect Immun       Date:  2016-12-29       Impact factor: 3.441

5.  A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulators.

Authors:  Dejan Caglič; Kristin M Bompiani; Michelle C Krutein; Petr Čapek; Tobin J Dickerson
Journal:  J Vis Exp       Date:  2013-12-27       Impact factor: 1.355

Review 6.  Toxins from bacteria.

Authors:  James S Henkel; Michael R Baldwin; Joseph T Barbieri
Journal:  EXS       Date:  2010

7.  Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1.

Authors:  Christina L Pier; Chen Chen; William H Tepp; Guangyun Lin; Kim D Janda; Joseph T Barbieri; Sabine Pellett; Eric A Johnson
Journal:  FEBS Lett       Date:  2010-11-30       Impact factor: 4.124

8.  Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Authors:  Dongxia Wang; Joan Krilich; Sabine Pellett; Jakub Baudys; William H Tepp; John R Barr; Eric A Johnson; Suzanne R Kalb
Journal:  Biochim Biophys Acta       Date:  2013-10-02

9.  The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Authors:  Rahman M Mizanur; Verna Frasca; Subramanyam Swaminathan; Sina Bavari; Robert Webb; Leonard A Smith; S Ashraf Ahmed
Journal:  J Biol Chem       Date:  2013-06-18       Impact factor: 5.157

10.  Llama single domain antibodies specific for the 7 botulinum neurotoxin serotypes as heptaplex immunoreagents.

Authors:  Jerry O Conway; Laura J Sherwood; M Thelma Collazo; John A Garza; Andrew Hayhurst
Journal:  PLoS One       Date:  2010-01-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.